Administration Nominates Two To Fill Top Posts At NIH, NSF

WASHINGTON-The Bush administration last month shaped the course of the two most important agencies for academic science within the federal bureaucracy by identifying its candidates for the directorships of the National Institutes of Health and the National Science Foundation. Its choices also suggest that presidential science adviser Allan Bromley has gained the upper hand in such personnel decisions over a range of competing interests within the White House. The selection of cardiologist Berna

Written byJeffrey Mervis
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

WASHINGTON-The Bush administration last month shaped the course of the two most important agencies for academic science within the federal bureaucracy by identifying its candidates for the directorships of the National Institutes of Health and the National Science Foundation. Its choices also suggest that presidential science adviser Allan Bromley has gained the upper hand in such personnel decisions over a range of competing interests within the White House.

The selection of cardiologist Bernadine Healy, vice president of the research institute at the Cleveland Clinic Foundation, to head NIH is expected to dispel criticism over a 14-month delay in replacing James Wyngaarden, who was forced out after seven years on the job. Healy's name was leaked to the press on September 9, and officials from the Department of Health and Human Services (HHS) later confirmed that her name would be sent to the Senate for confirmation once the mandatory background checks ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies